Psychiatry and Neurology, Neurology · Uniontown, OH
NPI
1306924964
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3838 Massillon Rd
Uniontown, OH, 44685
Phone (330) 896-9625
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
42,303 services
Medicare patients, 2024
67
Average age 65
Drug cost, 2024
$2.9M
2,268 prescriptions
Company payments, 2025
$2,514
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher A Sheppard was code J2350 (injection, ocrelizumab, 1 mg), 18,304 times for 23 patients. In total Christopher A Sheppard billed 42,303 services in 13 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 18,304 | 23 | $45.59 | $834K |
| 96415 Chemotherapy Administration | Office | 129 | 25 | $19.44 | $2,507 |
| 96413 Chemotherapy Administration | Office | 87 | 34 | $88.47 | $7,697 |
| 99214 Office E&M - Established | Office | 56 | 40 | $76.99 | $4,312 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 52 | 22 | $0.22 | $11.67 |
| 96375 Injection Administration | Office | 44 | 25 | $10.98 | $483 |
| J2930 Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 15 | 14 | $4.38 | $65.69 |
By year: 2022 $1.1M for 33,648 services; 2023 $894K for 28,506 services; 2024 $1.3M for 42,303 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher A Sheppard prescribed most often to Medicare patients was Baclofen, with 343 prescriptions and refills. In total Christopher A Sheppard wrote 2,268 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 343 | 538 | 69 | $7,574 |
| Gabapentin Generic | 238 | 382 | 47 | $4,342 |
| Dalfampridine Er Dalfampridine | 135 | 189 | 20 | $37K |
| Clonazepam Generic | 121 | 143 | 23 | $468 |
| Tizanidine Hcl Generic | 100 | 168 | 23 | $2,572 |
| Glatiramer Acetate Generic | 98 | 118 | 12 | $295K |
| Duloxetine Hcl Generic | 79 | 148 | 18 | $1,056 |
| Teriflunomide Generic | 78 | 94 | 11 | $215K |
| Modafinil Generic | 64 | 73 | 15 | $4,318 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 63 | 99 | 11 | $5,241 |
| Kesimpta Pen Ofatumumab | 58 | 58 | 12 | $573K |
| Nuedexta Dextromethorphan Hbr/Quinidine | 53 | 53 | Under 11 | $82K |
| Amantadine Amantadine Hcl | 49 | 65 | 11 | $1,197 |
| Myrbetriq Mirabegron | 48 | 70 | Under 11 | $31K |
| Carbamazepine Generic | 48 | 72 | Under 11 | $2,835 |
Brand drugs: - claims; generic drugs: 1,953 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher A Sheppard $2,514 ($2,514 in general payments such as food, travel and fees) from 13 companies. The largest payer was Genentech USA, Inc. with $497.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 24 | $497 |
| TG Therapeutics, Inc. TGTX | 10 | $412 |
| Biogen, Inc. BIIB | 14 | $393 |
| EMD Serono, Inc. MRK.DE | 15 | $347 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $199 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $175 |
| Celgene Corporation BMY | 7 | $123 |
| Genzyme Corporation SNY | 5 | $118 |
| Genentech, Inc. ROG.SW | 3 | $83.34 |
| Amgen Inc. AMGN | 3 | $54.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.